ATP6V0C and breast carcinoma: Further evidence for the role of V-ATPases in chemoresistance was reported from targeted molecular studies: small interfering RNA against the ATP6L subunit of proton pump V-ATPase was shown to attenuate chemoresistance of breast cancer cells [16] and hepatocellular carcinoma xenografts [20].